Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. May 7, 2010; 16(17): 2120-2128
Published online May 7, 2010. doi: 10.3748/wjg.v16.i17.2120
Table 3 Effects of the administration of 131I-labeled gelatin microspheres on hepatic function (n = 4)
ALT (IU/L)AST (IU/L)ALP (IU/L)GGT (IU/L)TP (g/L)ALB (g/L)GLB (g/L)
Before administration67.75 ± 11.8755.00 ± 11.8799.75 ± 14.996.00 ± 1.8354.33 ± 3.1646.05 ± 2.328.28 ± 2.79
After administration
1 d291.50 ± 12.79146.00 ± 13.88115.00 ± 25.929.25 ± 3.3060.23 ± 1.9645.65 ± 5.1715.00 ± 5.34
4 d46.75 ± 4.7941.25 ± 10.6991.00 ± 29.597.25 ± 1.2658.43 ± 8.4547.55 ± 3.5312.23 ± 5.03
8 d48.50 ± 14.3948.00 ± 17.3279.75 ± 14.777.50 ± 0.5858.10 ± 4.4044.63 ± 2.3313.65 ± 4.33
16 d37.25 ± 9.3239.75 ± 11.8176.00 ± 9.839.50 ± 3.1162.13 ± 5.8444.38 ± 7.4119.85 ± 6.79
24 d46.50 ± 16.0145.25 ± 9.9596.25 ± 17.088.00 ± 2.8360.28 ± 4.4547.60 ± 7.3814.50 ± 3.54
32 d52.25 ± 14.2946.25 ± 8.6696.75 ± 35.5812.50 ± 3.8763.55 ± 4.9046.40 ± 4.0618.63 ± 6.72
48 d43.75 ± 10.0140.25 ± 14.4597.25 ± 7.939.25 ± 1.7160.78 ± 4.0846.83 ± 4.0614.23 ± 4.22
64 d45.50 ± 4.8045.75 ± 3.2491.75 ± 29.6210.50 ± 3.4261.92 ± 8.1850.15 ± 5.3015.05 ± 3.89